Amoebic meningoencephalitis: We need to be more evidence based

Amoebic meningoencephalitis (AME) in India is on the rise each year, presenting a growing concern for public health. Despite its rarity, the high fatality rate associated with this amoeba poses a significant challenge. With India's abundant freshwater reservoirs, there is a potential risk of AME spreading to a larger population, as evidenced by a few reported deaths in various states, prompting concern among public health experts and healthcare professionals. Given the sporadic nature of AME cases and the lack of a robust treatment landscape and infrastructure, along with a shortage of well-trained healthcare personnel, patients are often diagnosed in advanced stages and face fatal outcomes. It is imperative to enhance our public health system and operational strategies to effectively address such emerging health threats. By implementing advanced diagnostic techniques, efficient treatment plans, and evidence-based practices to strengthen the healthcare workforce, we can better prepare ourselves to combat unforeseen and challenging healthcare scenarios. The current editorial delves into India's readiness to manage AME, focusing on epidemiology, diagnostic capabilities, treatment protocols, public health strategies, and research endeavors. It identifies existing gaps and offers recommendations to bolster the country's capacity to tackle this emerging health crisis.